Charles Schwab Investment Management Inc. grew its stake in Option Care Health, Inc. (NASDAQ:OPCH - Free Report) by 4.0% during the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 2,609,705 shares of the company's stock after purchasing an additional 99,574 shares during the period. Charles Schwab Investment Management Inc. owned about 1.59% of Option Care Health worth $91,209,000 as of its most recent SEC filing.
Other hedge funds and other institutional investors also recently bought and sold shares of the company. Compass Wealth Management LLC grew its position in Option Care Health by 8.9% in the 1st quarter. Compass Wealth Management LLC now owns 166,078 shares of the company's stock worth $5,804,000 after purchasing an additional 13,600 shares during the last quarter. Bessemer Group Inc. grew its position in Option Care Health by 62.3% in the 1st quarter. Bessemer Group Inc. now owns 1,560 shares of the company's stock worth $54,000 after purchasing an additional 599 shares during the last quarter. Principal Financial Group Inc. grew its position in Option Care Health by 1.4% in the 1st quarter. Principal Financial Group Inc. now owns 485,871 shares of the company's stock worth $16,981,000 after purchasing an additional 6,616 shares during the last quarter. Wealth Enhancement Advisory Services LLC boosted its position in shares of Option Care Health by 25.7% during the 1st quarter. Wealth Enhancement Advisory Services LLC now owns 8,274 shares of the company's stock valued at $289,000 after acquiring an additional 1,691 shares in the last quarter. Finally, GAMMA Investing LLC boosted its position in shares of Option Care Health by 307.1% during the 1st quarter. GAMMA Investing LLC now owns 3,192 shares of the company's stock valued at $112,000 after acquiring an additional 2,408 shares in the last quarter. 98.05% of the stock is currently owned by institutional investors and hedge funds.
Option Care Health Price Performance
Shares of NASDAQ OPCH traded down $0.09 during trading on Friday, reaching $28.32. The company had a trading volume of 1,179,882 shares, compared to its average volume of 1,593,526. Option Care Health, Inc. has a 52 week low of $21.39 and a 52 week high of $35.53. The stock has a market cap of $4.60 billion, a PE ratio of 22.66, a PEG ratio of 1.80 and a beta of 0.79. The company has a debt-to-equity ratio of 0.81, a quick ratio of 1.00 and a current ratio of 1.52. The business's 50 day moving average price is $30.29 and its 200-day moving average price is $31.85.
Option Care Health (NASDAQ:OPCH - Get Free Report) last announced its earnings results on Wednesday, July 30th. The company reported $0.41 earnings per share for the quarter, topping analysts' consensus estimates of $0.40 by $0.01. Option Care Health had a net margin of 3.93% and a return on equity of 17.53%. The company had revenue of $1.42 billion during the quarter, compared to the consensus estimate of $1.35 billion. During the same period in the previous year, the firm posted $0.30 earnings per share. The company's revenue was up 15.4% on a year-over-year basis. Analysts expect that Option Care Health, Inc. will post 1.22 earnings per share for the current year.
Analyst Ratings Changes
Several analysts have recently weighed in on OPCH shares. JMP Securities lifted their target price on shares of Option Care Health from $36.00 to $38.00 and gave the company a "market outperform" rating in a research report on Thursday, July 31st. Citigroup reiterated an "outperform" rating on shares of Option Care Health in a research report on Thursday, July 31st. UBS Group upgraded shares of Option Care Health from a "neutral" rating to a "buy" rating and lifted their target price for the company from $38.00 to $40.00 in a research report on Wednesday, April 30th. Finally, Barrington Research reiterated an "outperform" rating and set a $38.00 target price on shares of Option Care Health in a research report on Thursday, July 10th. One investment analyst has rated the stock with a hold rating and eight have given a buy rating to the company. According to data from MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and an average target price of $35.75.
Check Out Our Latest Stock Report on OPCH
Option Care Health Profile
(
Free Report)
Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.
Read More
Before you consider Option Care Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Option Care Health wasn't on the list.
While Option Care Health currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
MarketBeat All Access